← Evidence map

ArticleDrugs in R&D2015

Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products.

Jürgen FrevertPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 25851380